Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative, differentiated products to address unmet medical needs. The company's primary function revolves around the development of proprietary drug delivery platforms, particularly its PharmFilm® technology, which allows the delivery of medication in the form of oral films. Aquestive’s solutions are designed to improve the ease of drug administration, enhance patient compliance, and address specific medical challenges such as epilepsy and severe allergic reactions. Aquestive Therapeutics operates primarily within the pharmaceutical and healthcare sectors, tapping into a wide spectrum of therapeutic areas where its novel delivery methods can offer significant advancements. The company's market significance is underscored by its ability to transform existing therapies into more user-friendly formats, potentially extending the lifecycle and reach of key pharmaceuticals. Through strategic partnerships and in-house research, Aquestive Therapeutics continues to innovate, contributing to the evolving landscape of drug delivery technologies and patient care.